MYCOPHENOLATE MOFETIL AND THE INCIDENCE OF SKIN CANCER IN KIDNEY TRANSPLANT RECIPIENTS

被引：0
|
作者：
Yusuf, Sarah [1 ]
Bheemreddy, Himaja [1 ]
Ahmed, Imtiaz [2 ]
Krishnan, Nithya [3 ]
机构：
[1] Coventry Univ, Fac Hlth & Life Sci, Coventry, W Midlands, England
[2] Univ Hosp Coventry & Warwickshire, Dermatol, Coventry, W Midlands, England
[3] Univ Hosp Coventry & Warwickshire, Renal Transplantat & Nephrol, Coventry, W Midlands, England
来源：
TRANSPLANTATION | 2020年 / 104卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P-18.02
引用
收藏
页码：S603 / S603
页数：1
相关论文
共 50 条
  • [41] Pharmacokinetics of Mycophenolate Mofetil and Development of Limited Sampling Strategy in Early Kidney Transplant Recipients
    Zhang, Jun
    Sun, Zhi
    Zhu, Zhenfeng
    Yang, Jing
    Kang, Jian
    Feng, Guiwen
    Zhou, Lin
    Zuo, Lihua
    Luo, Yonggang
    Zhang, Xiaojian
    FRONTIERS IN PHARMACOLOGY, 2018, 9
  • [42] BK Virus Infection and Mycophenolate Mofetil Exposure in Pediatric Kidney Transplant Recipients.
    Singh, Nisha
    Stone, Hillarey
    Chadha, Vimal
    VanSickle, Judith S.
    Sherman, Ashley
    Rahman, Susan
    Warady, Bradley
    PEDIATRIC NEPHROLOGY, 2023, 38 (07) : 2344 - 2345
  • [43] COMPARATIVE BIOAVAILABILITY STUDY OF TWO MYCOPHENOLATE MOFETIL FORMULATIONS IN STABLE KIDNEY TRANSPLANT RECIPIENTS
    Sunder-Plassmann, Gere
    Reinke, Petra
    Rath, Thomas
    Wiecek, Andrzej
    Nowicki, Michal
    Moore, Richard
    Lutz, Jens
    Gaggl, Martina
    Ferkl, Marek
    TRANSPLANT INTERNATIONAL, 2011, 24 : 81 - 81
  • [44] Pharmacometabolomics identified nonactivated metabolites of azathioprine and mycophenolate mofetil in urine of kidney transplant recipients
    Klont, Frank
    Bakker, Stephan J. L.
    Hak, Eelko
    Touw, Daan J.
    Hopfgartner, Gerard
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I1616 - I1616
  • [45] Safety and Efficacy of a Preemptive Mycophenolate Mofetil Dose Reduction Strategy in Kidney Transplant Recipients
    Yatim, Karim
    Al Jurdi, Ayman
    El Mouhayyar, Christopher
    Morena, Leela
    Hullekes, Frank E.
    Verhoeff, Ruchama
    Ribas, Guilherme T.
    Pearson, Daniel S.
    Riella, Leonardo, V
    TRANSPLANTATION DIRECT, 2024, 10 (09):
  • [46] Primary immunosuppression with mycophenolate mofetil and antithymocyte globulin for kidney transplant recipients of a suboptimal graft
    Grinyo, JM
    Gil-Vernet, S
    Seron, D
    Hueso, M
    Fulladosa, X
    Cruzado, JM
    Moreso, F
    Fernandez, A
    Torras, J
    Riera, L
    Castelao, AM
    Alsina, J
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1998, 13 (10) : 2601 - 2604
  • [47] Effect of mycophenolate mofetil regimen on peripheral blood lymphocyte subsets in kidney transplant recipients
    Soto, JAB
    de la Rosa, RJE
    del Castillo, JDL
    Morales, SC
    Olivares, EG
    Ortega, AO
    Peinado, CA
    TRANSPLANTATION PROCEEDINGS, 2003, 35 (04) : 1355 - 1359
  • [48] Unexpected rate of severe leucopenia with the association of mycophenolate mofetil and valganciclovir in kidney transplant recipients
    Rerolle, Jean-Philippe
    Szelag, Jean-Christophe
    Le Meur, Yann
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 (02) : 671 - 672
  • [49] Mycophenolate mofetil versus azathioprine in simultaneous pancreas-kidney transplant recipients on cyclosporine
    Fabrega, AJ
    Corwin, CL
    Hunsicker, L
    TRANSPLANTATION PROCEEDINGS, 1998, 30 (04) : 1562 - 1563
  • [50] Concomitant Proton Pump Inhibitors With Mycophenolate Mofetil and the Risk of Rejection in Kidney Transplant Recipients
    Knorr, John P.
    Sjeime, Mariel
    Braitman, Leonard E.
    Jawa, Pankaj
    Zaki, Radi
    Ortiz, Jorge
    TRANSPLANTATION, 2014, 97 (05) : 518 - 524
12345